A 4 month growth monitoring study of healthy term infants fed iron fortified infant formula. Infants will be fed ad-libitum for 16 weeks and growth will be evaluated in terms of weight gain over the 16 weeks.
A Growth Monitoring Study conducted according to FDA established guidelines to evaluate the test infant formulas ability to promote normal growth and development.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
518
Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period
Weight gain (g) from study entry to 16 weeks of study.
Growth Monitoring Study
Time frame: 16 weeks of Clinical Study
Recumbent length gain (cm) from study entry to 16 weeks of study.
Growth Monitoring Study
Time frame: 16 weeks of Clinical Study
Head Circumference gain (cm) from study entry to 16 weeks of study
Growth Monitoring Study
Time frame: 16 weeks of Clinical Study
Tolerance of study formulas over 16 weeks of study
Tolerance of the infant to the study formulas will be evaluated 5 times through the use of study diaries for 3 days before each study visit.
Time frame: 16 weeks of Clinical Study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Velocity Clinical Research-Phoenix
Phoenix, Arizona, United States
Advance Pediatric Associates
Centennial, Colorado, United States
Symphony Clinical Research
Jacksonville, Florida, United States
Clintheory Healthcare Miami
North Miami Beach, Florida, United States
PAS Research Tampa
Tampa, Florida, United States
UpTo Trials
Tampa, Florida, United States
Backtee Holdings, LLC
Wellington, Florida, United States
Velocity Clinical Research-Macon
Macon, Georgia, United States
Leavitt Clinical Research
Idaho Falls, Idaho, United States
Kentucky Pediatric Research
Bardstown, Kentucky, United States
...and 19 more locations